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1. Introduction 
Diabetes mellitus is a common metabolic syndrome that has become an epidemic in modern 
society and is characterized by either a near-complete lack of insulin production due to 
autoimmune destruction of pancreatic beta-cells as in type 1 diabetes or abnormal insulin 
secretion, beta-cell dysfunction and insulin resistance as in type 2 diabetes (T2D). T2D is a 
complex heterogeneous disease that is characterized by elevated fasting and postprandial 
blood glucose levels that can result in severe complications including renal failure, 
cardiovascular disease, blindness and slow wound healing (Lin and Sun, 2010). Pancreatic 
islet beta-cells play a critical role in maintaining blood glucose levels by secreting the 
hormone insulin following a meal. Insulin maintains blood glucose levels in the normal 
physiological range by promoting glucose uptake in muscles, liver and adipose tissue, and 
by inhibiting hepatic glucose production. Therefore, any defect in insulin secretion in 
response to a meal or defects in insulin action in peripheral tissues can lead to increased 
blood glucose levels (Tripathy and Chavez, 2010; Muoio & Newgard, 2008).  
Abnormal insulin secretion is a hallmark of T2D. Despite the central role of insulin in 
maintaining glucose homeostasis, the fundamental biochemical mechanism regulating 
nutrient-stimulated insulin secretion from pancreatic beta-cells is still incompletely 
understood. Insulin secretion from the pancreatic beta-cells is regulated by nutrients, 
neurotransmitters and hormones. Among these three factors, nutrients, particularly glucose 
is the most dominant stimulatory signal for insulin secretion. Insulin secretion is biphasic 
with a first acute phase occurring within 10 minutes after a glucose load and a second more 
sustained phase that reaches a plateau very quickly as seen in mice or more gradually as 
seen in rats and humans (Gerich, 2002). Numerous models have been proposed over the last 
several decades to explain the mechanism governing glucose-stimulated insulin secretion 
(GSIS) from pancreatic beta-cells. The current model of GSIS holds that glucose enters beta-
cells via the low affinity, high capacity glucose transporter 2 (GLUT2) and becomes 
phosphorylated by glucokinase (GK or hexokinase IV), which is the rate-limiting step in 
glycolysis. The glycolytic end product pyruvate then enters the tricarboxylic acid cycle 
(TCA), where oxidative phosphorylation occurs, leading to increased ATP production. The 
subsequent rise in the cytosolic ATP/ADP levels promotes closure of ATP-sensitive 
potassium channels (KATP channels) causing beta-cell membrane depolarization and 
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activation of voltage-dependent Ca2+ channels (VDCC). The opening of VDCCs facilitates 
influx of extracellular Ca2+, leading to a rise in the beta-cell cytosolic Ca2+ levels, which triggers 
exocytosis of the insulin-containing secretory granules (Figure 1) (Jensen et al., 2008; Prentki & 
Matchinsky, 1987; Ashcroft & Rorsman, 1989; Newgard & Matchinsky, 2001; Newgard & 
McGarry, 1995). This so-called “KATP channel-dependent” mechanism appears to be 
particularly important for the first, acute phase of insulin release. However, in the second and 
more sustained phase of insulin secretion a “KATP channel-independent” pathway also appears 
to play a key role in the regulation of GSIS in conjunction with the KATP channel-dependent 
pathway (Henquin et al., 2003, Ravier et al., 2009). Important support for “KATP channel-
independent” pathway of GSIS comes from studies showing that glucose still causes a 
significant increase in insulin secretion in conditions where KATP channels are held open by 
application of diazoxide followed by membrane depolarization with high K+, or in animals 
lacking functional KATP channels (Nenquin et al., 2004; Shiota et al., 2002; Szollozi et al., 2007; 
Ravier et al., 2009). These and more recent studies suggest that mitochondrial metabolism of 
glucose generates signals other than changes in the ATP/ADP ratio that are important for 
normal insulin secretion. Several molecules, including glutamate, malonyl-CoA/LC-CoA and 
NADPH, have been proposed as candidate coupling factors in GSIS (Maechler & Wollheim, 
1999; Ivarsson et al., 2005; Corkey et al., 1989; Prentki et al., 1992).  
 
Fig. 1. Current model of glucose stimulated insulin secretion (GSIS) from pancreatic beta-
cells. Glucose equilibrates across the plasma membrane through glucose transporter GLUT2, 
which initiates glycolysis. Pyruvate produced by glycolysis preferentially enters the 
mitochondria and is metabolized in the TCA cycle, producing reducing equivalents in the 
form of NADH and FADH2. The transfer of electrons from these reducing equivalents 
through the mitochondrial electron transport chain is coupled with the pumping of protons 
from the mitochondrial matrix to the inter membrane space, leading to the generation of 
ATP. ATP is transferred to the cytosol through adenine nucleotide carrier (ANC), raising the 
ATP/ADP ratio. This results in the closure of the ATP sensitive K+ channels (KATP), which in 
turn leads to membrane depolarization, opening of the voltage-sensitive Ca2+ channels, 
promoting calcium entry and increase in cytoplasmic Ca2+ leading to exocytosis of insulin 
granules. Glucose also generates amplifying signals other than ATP, which plays a 
significant role in the secretion of insulin from pancreatic beta-cells. 
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Maintenance of a functional mature beta-cell phenotype requires optimal expression of 
key transcription factors. Transcription factors regulate a variety of pancreatic beta-cell 
processes including cell differentiation, proliferation, cell signaling and apoptosis. By 
regulating the expression of specific sets of genes, transcription factors determine the 
spatio-temporal specificity of gene expression in most organisms, including mammals. 
Numerous studies have shown that transcription factors act synergistically to achieve 
normal beta-cell development and function (Cerf, 2006; Mitchell & Frayling, 2002; Lyttle et 
al., 2008). Development of the endocrine pancreas is initiated from multipotent precursor 
cells, which differentiate to form five different cell types in the pancreatic islet namely the 
┙-cells (glucagon), ┚-cells (insulin), -cells (somatostatin), PP (pancreatic polypeptide) 
cells and -cells (ghrelin) (Steiner et al., 2010). The development of the islet architecture is 
regulated by an ordered system of transcriptional events activated by a hierarchy of 
transcription factors. Some of the major transcription factors represented in islets include 
several homeodomain factors like pancreatic and duodenal homeobox-1 (Pdx-1), paired 
box gene (Pax) Pax 4, Pax 6, Nkx 2.1 and Nkx 6.1 which are expressed in both progenitor 
as well as differentiated beta-cells. Pdx-1 and Nkx 2.2 are required for both early beta-cell 
differentiation and maintenance of a mature beta-cell phenotype (Habner et al., 2005). In 
addition, other transcription factors are important for maintenance of a mature beta-cell 
phenotype and their impairment may account for various pathophysiological 
abnormalities observed in type 2 diabetics. Among these, Pdx-1, neurogenin 
differentiation (NeuroD/BETA-2), foxhead box protein (FoxO-1), sterol regulatory 
element binding protein (SREBP-1c), and musculoaponeurotic fibrosarcoma oncogene 
homolog A (MafA) are the most studied (Johnson et al., 1994; Diraison et al., 2004; 
Kitamura et al., 2005).  
In the context of T2D, it is a well-known fact that abnormal gene expression contributes to 
a myriad of beta-cell abnormalities. Support for this comes from studies of maturity-onset 
diabetes of the young (MODY), a monogenic form of T2D characterized by an early onset 
and defects in insulin secretion leading to hyperglycemia. With the exception of MODY-2, 
which is caused by a mutation in GK, MODY-1, 3, 4, 5 and 6 result from mutations in 
genes encoding transcription factors, hepatocyte nuclear factor (HNF) HNF-4┙, HNF-1┙, 
HNF-1┚, Pdx-1, and NeuroD/BETA-2 respectively. These transcription factors regulate 
the expression of key genes involved in various aspects of beta-cell function (Stoffer & 
Zinkin, 1997; Habener et al., 1998; Fajans et al., 2001; Yamagata et al, 2003). Although 
there have been significant advancements in understanding the basic transcriptional 
network that exists in beta-cells, the exact mechanism of action of many of these factors 
still remains to be further defined. In this chapter we provide an overview of one of the 
recently described transcription factor in the context of impaired insulin secretion and 
beta-cell dysfunction, Aryl hydrocarbon receptor nuclear translocator (ARNT)/ hypoxia 
inducible factor 1┚ (HIF-1┚), which is a master regulator of pancreatic beta-cell 
transcriptional network that regulates glucose metabolism and insulin secretion.  
2. ARNT/HIF-1β 
2.1 ARNT/HIF-1β structure and function  
ARNT/HIF-1┚ belongs to a group of transcription factors, known as the basic helix loop 
helix - PER/ARNT/Sim (bHLH-PAS) family, which has a characteristic N-terminal bHLH 
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motif for DNA binding, a central PAS domain which facilitates heterodimerization and a C-
terminal transactivation domain for the recruitment of transcriptional coactivators such as 
CBP/p300 (Jain et al., 1994; Kobayashi et al., 1997). Recent evidence suggest that the PAS 
domain may also provide an additional binding site for coactivators and thereby recruiting 
them in a step necessary for transcriptional responses to hypoxia (Partch & Gardener, 2011). 
ARNT/HIF-1┚ acts as a common binding partner for most of the bHLH-PAS family of 
transcription factors and bind specific DNA sequences in the regulatory regions of the 
responsive genes. The half-site for ARNT/HIF-1┚ is on the 3' side of the 5'-GTG-3' 
recognition sequence. The sequence of the other half of the binding site depends upon the 
identity of the ARNT/HIF-1┚ dimerization partner (Swanson et al., 1995). DNA binding of 
ARNT/HIF-1┚ is mediated by its bHLH region and may also involve the PAS region. 
Dimerization between ARNT/HIF-1┚ and other bHLH-PAS proteins is mediated by their 
bHLH and PAS regions (Jiang et al., 1996, Lindebro et al., 1995). The human ARNT/HIF-1┚ 
gene is about 65 Kb in size, has 22 exons and is well conserved on an evolutionary scale 
(Scheel & Schrenk, 2000).  
ARNT/HIF-1┚ was originally cloned as a factor required for the activity of the aryl 
hydrocarbon receptor (AhR). AhR induces a transcriptional response to various 
environmental pollutants, such as polycyclic aromatic hydrocarbons, heterocyclic amines, 
and polychlorinated aromatic compounds (Reyes et al., 1992). ARNT/HIF-1┚ was also 
identified as the ┚-subunit of a heterodimeric transcription factor, hypoxia-inducible factor 
1┙ (HIF-1┙) (Wang et al., 1995 (a)). Similar to HIF-1┙, ARNT/HIF-1┚ gene expression and 
protein levels are significantly increased under hypoxic conditions suggesting that this gene 
plays an important role in the transcriptional response to low oxygen tension (Wang et al., 
1995 (b)). Consistent with this idea, it has been shown that ARNT/HIF-1┚ is essential for the 
hypoxic induction of vascular endothelial growth factor (VEGF) and the glycolytic enzymes 
aldolase A (ALDO) and phosphoglycerate kinase (PGK) in a mouse hepatoma (Hepa 1c1c7) 
cell line (Li et al., 1996; Salceda et al., 1996). Unlike HIF-1┙, which is exclusively expressed 
under hypoxic conditions, ARNT/HIF-1┚ is constitutively expressed in a number of tissues, 
such as the brain, heart, kidney, muscles, thymus, retina, olfactory epithelium and beta-cells 
of pancreas (Hirose et al., 1996).  
2.2 ARNT/HIF-1β localization, binding partners, mechanism of action and lessons 
from knockout animals 
ARNT/HIF-1┚ is a nuclear protein in most cell types, although it may also be located in the 
cytosol, particularly during embryogenesis. Studies conducted by Holmes and Pollenz 
(1997) in hepatic and non-hepatic cell lines derived from rat, mouse, human, and canine 
tissues confirm ARNT/HIF-1┚ as a nuclear transcription factor and showed that its physical 
interaction with DNA requires entry into the nucleus.  
ARNT/HIF-1┚ serves as an obligatory binding partner for a number of other bHLH-PAS 
proteins, whose activity is modulated either by exogenous chemicals (AhR), hypoxia (HIF-
1┙, HIF-2┙ and HIF-3┙), or which show tissue-specific expression pattern (e.g. SIM-1) 
(Salceda et al., 1996; Swanson et., 1995; Woods & Whitelaw, 2002). In addition to forming 
heterodimers, ARNT/HIF-1┚ appears to be capable of forming homodimers and bind to an 
E-box sequence 5'-CACGTG-3' (Antonsson et al., 1995). It was also shown that ARNT/HIF-
1┚ homodimer regulates the transcription of murine cytochrome P450 (Cyp) 2a5 gene 
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through a palindromic E-box element in the 5' regulatory region of Cyp2a5 gene in primary 
hepatocytes (Arpiainen et al., 2007). Two ARNT-related genes, ARNT-2 and ARNT-3 (also 
called BMAL-1 or MOP3) have been identified. ARNT-2 is more restricted in expression 
than ARNT/HIF-1┚, but appears to dimerize with the same partner proteins as ARNT/HIF-
1┚ (Hirose et al., 1996). ARNT-3 appears to have different dimerization potential than 
ARNT/HIF-1┚ (Ikeda & Nomura, 1997). The transactivation potential of ARNT/HIF-1┚ is 
not only determined through the recruitment of transcriptional cofactors, but also by 
signaling input from several protein kinases, such as PKC (Long et al., 1999).  
The ARNT/HIF-1┚/AhR heterodimer activates transcription of several genes involved in 
metabolism of foreign chemicals, including CYP1A1, CYP1B1, and NADP(H):oxidoreductase 
(NQO1) (Sogawa & Kuriayama, 1997; Beischlag et al., 2008). Transcriptional activation of these 
genes depends upon prior binding of AhR to xenobiotic ligands, including 2,3,7,8-
tetrachlorodibenzo-p-dioxin (dioxin) and benzopyrene. The ARNT/HIF-1┚/AhR heterodimer 
and ARNT/HIF-1┚ can have an impact on estrogen receptor (ER) activity. ARNT/HIF-1┚ 
interacts and functions as a potent coactivator of both ER-┙ and ER-┚ dependent transcription 
and it is believed that the C-terminal domain of ARNT/HIF-1┚ is essential for the 
transcriptional enhancement of ER activity (Lim et al., 2011;Rüegg et al., 2008).  
ARNT/HIF-1┚/HIF-1┙ heterodimer activity is primarily regulated by HIF-1┙ protein 
stability. Under normoxia, HIF-1┙ is hydroxylated by an oxygen requiring enzyme, prolyl 
hydroxylase (PHD), which is then targeted for ubiquitination by the E3 ubiquitin ligase, 
followed by binding to von Hippel-Lindau tumor suppressor (VHL) which leads to 
degradation of HIF-1┙ by the proteasome pathway. Conversely, under hypoxic conditions, a 
lack of oxygen inhibits hydroxylation, leading to stabilization of the HIF-1┙ protein and 
translocation of HIF-1┙ from the cytoplasm to the nucleus. In the nucleus, 
heterodimerization of HIF-1┙ with ARNT/HIF-1┚ is followed by binding to hypoxia 
response elements (HRE) in the promoter region of the target genes (Fedele et al., 2002) 
(Figure 2). Like HIF-1┙, HIF-2┙ and 3┙ are stabilized by hypoxia and hypoglycemia, and 
activate transcription of genes involved in adapting to these adverse conditions, including 
the genes for erythropoietin (EPO), VEGF, and a number of enzymes of glycolysis including 
ALDO, phosphofructokinase (PFK) and lactate dehydrogenase (LDH) (Maltepe et al., 1997; 
Fraisl et al., 2009; Fedele et al., 2002). These studies suggest ARNT/HIF-1┚ is a central player 
in a number of signaling pathways and alterations in its activity can have serious impact on 
cellular responses to hypoxia, dioxin response and estrogen signaling in mammalian cells. 
Observations from the ARNT/HIF-1┚ conditional knockout mice and whole body knockout 
mice have provided a wealth of information regarding the functional significance of this 
transcription factor in mammalian cells. Results obtained from the ARNT/HIF-1┚ null mice 
suggest that it plays a central role in embryonic development and physiological homeostasis as 
these mice are embryonic lethal due to severe defects in angiogenesis and placental 
development (Maltepe et al., 1997; Kozak et al., 1997). Data obtained from tissue specific 
ARNT/HIF-1┚ knockout mice demonstrates that disruption of ARNT/HIF-1┚ expression in 
liver and heart results in loss of AhR-stimulated gene transcription and that ARNT/HIF-1┚ is 
key to AhR function in these two mammalian tissues. It was also observed that ARNT/HIF-1┚ 
affects HIF-1┙ mediated target gene expression as several key genes including the expression 
of heme-oxygenase and glucose transporter-1 mRNA was abolished after treatment with 
CoCl2, an agent that is thought to mimic hypoxia (Tomita et al., 2000). 
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Fig. 2. Overview of gene regulation by ARNT/HIF-1┚/HIF-1┙ complex in mammalian cells 
under normoxic and hypoxic conditions. In normoxic conditions, HIF-1┙ protein undergoes 
oxygen dependent hydroxylation by prolyl hydroxylases (PHD) and the hydroxylation site is 
recognized by pVHL, which targets the protein for ubiquitination by ubiquitin ligase, followed 
by degradation through ubiquitin proteasome pathway. During hypoxia, HIF-1┙ protein is not 
targeted for degradation and can translocate to the nucleus, where it heterodimerizes with 
ARNT/HIF-1┚ to form a stable transcriptional complex. The ARNT/HIF-1┚/HIF-1┙ 
heterodimer then binds to the hypoxia response element (HRE) of target genes.  
3. ARNT/HIF-1β and type 2 diabetes 
3.1 ARNT/HIF-1β is reduced in human diabetic islets  
In 2005, a study published in Cell (Gunton et al., 2005) suggested that ARNT/HIF-1┚, a 
transcription factor with previously unknown functions in beta-cells, plays a significant 
role in mediating human beta-cell dysfunction in type 2 diabetics. Genome-wide gene 
expression profiling of islets obtained from human non-diabetics and type 2 diabetics 
revealed that the expression levels of ARNT/HIF-1┚ was reduced by 90% under the 
diabetic conditions. This was associated with reduced expression levels of several 
ARNT/HIF-1┚ target genes involved in glycolysis and insulin signaling. Several enzymes 
in glycolysis, including phosphoglucomutase (PGM), phosphoglucose isomerase (G6PI), 
PFK and ALDO were expressed at significantly lower levels as compared to those 
observed in normal islets. The low ARNT/HIF-1┚ expression levels observed under 
diabetic conditions was also associated with low gene expression levels of several key 
regulators in insulin signaling, such as the insulin receptor (IR), insulin receptor substrate 
2 (IRS2), and protein kinase B (Akt2). Another interesting observation made in this study 
was that MODY genes, HNF-1┙ and HNF- 4┙, were poorly expressed in human islets 
obtained from type 2 diabetics. HNF-4┙, the gene mutated in MODY1, has been shown to 
interact with ARNT/HIF-1┚ possibly providing a connection between the two 
transcription factors (Tsuchiya et al., 2002). 
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In order to rule out the possibility that the profound ARNT/HIF-1┚ down regulation in 
pancreatic beta-cells is not caused by the diabetic environment, Gunton and co-workers 
demonstrated that an identical gene profile was observed in a beta-cell-specific 
ARNT/HIF-1┚ knockout mouse (┚-ARNT KO). ┚-ARNT KO mice exhibited impaired 
GSIS and glucose intolerance, with no significant change in beta-cell insulin content and 
islet mass. The finding that ARNT/HIF-1┚ knockout mice have normal islet mass suggests 
that this transcription factor does not play a role in beta-cell differentiation.  
Overall, a combination of in vivo and in vitro studies in humans and rodents have provided 
us with convincing evidence that reduction in ARNT/HIF-1┚ expression in human 
pancreatic beta-cells has negative consequences in terms of beta-cell function and insulin 
secretion. However, the extent of ARNT/HIF-1┚ mediated regulation of gene transcription 
is complex since it has the potential to bind with multiple partners affecting a multitude of 
signaling pathways.  
3.2 ARNT/HIF-1β is reduced in human diabetic hepatic cells  
In both rodents and humans, the liver plays a critical role in maintaining glucose and lipid 
homeostasis. During fasting, hepatic glucose production is critical for providing glucose 
for the brain, the kidneys and red blood cells. In liver, glucose is produced by 
glycogenolysis during the initial stages of fasting, however, after several hours of fasting, 
glucose production is primarily from gluconeogenesis, a process by which the liver 
produces glucose from precursors such as lactate and pyruvate (Michael et al., 2000; 
Saltiel & Kahn, 2001). Wang et al showed that ARNT/HIF-1┚ was severely reduced in the 
livers of human type 2 diabetics (Wang et al., 2009). Gene expression profiling of liver 
specimens from normal, obese and obese diabetic patients revealed a 30% reduction in the 
expression of ARNT/HIF-1┚ gene in obese diabetic individuals. The study demonstrated 
that the reduced expression of ARNT/HIF-1┚ in the livers of humans with T2D was 
associated with high glucose levels, high insulin levels, and insulin resistance. This study 
also suggested that insulin, not glucose regulates the expression of ARNT/HIF-1┚ gene 
and that ARNT/HIF-1┚ expression is reduced in both insulin-deficient and insulin-
resistant states. 
Wang et al (2009) also looked at the effects of liver-specific deletion of ARNT/HIF-1┚ gene 
in mice (L-ARNT KO) and demonstrated that there was an increase in gluconeogenesis, 
lipogenesis and increased serum insulin levels, all characteristic of human type 2 diabetics. 
The increase in hepatic gluconeogenesis and lipogenesis in L-ARNT KO mice was associated 
with the upregulation of several important gluconeogenic and lipogenic genes including 
PEPCK, G6Pase, SCD1 and FAS. Expression of C/EBP┙ and SREBP-1C, was also induced by 
2-folds in L-ARNT KO mice. C/EBP┙ plays a major role in kick-starting hepatic glucose 
production at birth, and disruption of the C/EBP┙ gene in mice is known to cause 
hypoglycemia associated with the impaired expression of the gluconeogenic enzymes 
PEPCK and G6Pase (Pedersen et al., 2007; Qiao et al., 2006). SREBP-1C, on the other hand is 
a major player in lipogenesis (Horton et al., 2002). ARNT/HIF-1┚ may act as an upstream 
regulator of these transcription factors and play a key role in maintaining whole body 
glucose and lipid homeostasis. However, as seen in pancreatic beta-cells, the exact pathways 
targeted by ARNT/HIF-1┚ in liver cells are not clearly understood and is complicated by 
the fact that ARNT/HIF-1┚ has multiple binding partners. 
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3.3 ARNT/HIF-1β regulates glucose metabolism and insulin secretion in beta-cells  
The central role played by ARNT/HIF-1┚/HIF-1┙ heterodimer in the regulation of glucose 
homeostasis, particularly glycolysis has been well studied (Dery et al., 2005; Semenza et al., 
1994) with a focus in cancer cell metabolism (Song et al., 2009; Semenza et al., 2000; Semenza, 
2003). It is widely accepted that ARNT/HIF-1┚/HIF-1┙ heterodimer plays a role in the 
Warburg effect, where cancer cells undergo a high rate of anaerobic glycolysis compared to 
normal cells. It has been suggested that the observed increase in glycolytic enzymes in these 
cancer cells is associated with increased HIF-1 activity, thus aiding in tumor formation and 
progression. Studies conducted in ARNT/HIF-1┚ mutant clonal cells indicate that it is an 
essential component of the HIF-1┙ complex and that absence of ARNT/HIF-1┚ leads to 
reduced cellular responses to stimuli such as hypoxia (Woods et al., 1996).  
In pancreatic beta-cells, metabolism of glucose through aerobic glycolysis and oxidative 
phosphorylation plays a significant role in maintaining a normal secretory capacity. Beta-
cells sense glucose and secrete appropriate amounts of insulin to promote glucose uptake by 
muscles and adipose tissue. Insulin also inhibits hepatic glucose production. Abnormal 
insulin secretion is one of the earliest detectable defects at the onset of T2D and despite its 
relevance, the mechanisms underlying GSIS are not completely understood. The generally 
accepted model of GSIS holds that metabolism of glucose in the beta-cells leads to a rise in 
the cytosolic ATP/ADP levels, which promotes closure of the KATP channel, increased 
cytosolic Ca2+ and triggers exocytosis of insulin-containing secretory granules (Henquin et 
al., 2003; Jensen et al., 2008). In beta-cells glucose derived pyruvate is directed mostly 
towards TCA for the production of ATP, since both the pentose phosphate pathway and 
anaerobic glycolysis is relatively inactive (Schuit et al., 1997). This exceptionally high 
dependence of beta-cells on the TCA cycle suggests that hypoxia or mechanisms reducing 
the aerobic capacity of beta-cells would probably have profound effects on GSIS. 
It has been shown that down regulation of ARNT/HIF-1┚ in pancreatic beta-cells leads to loss 
of GSIS (Gunton et al., 2005; Pillai et al 2011). Our group has demonstrated that beta-cells with 
reduced ARNT/HIF-1┚ expression levels exhibit a 31% reduction in glycolytic flux without 
significant changes in glucose oxidation or the ATP/ADP ratio. Metabolomics analysis 
revealed that clonal beta-cells (832/13) treated with siRNAs against the ARNT/HIF-1┚ gene 
have lower levels of glycolytic, TCA cycle and fatty acid intermediates (Figure 3). It was also 
shown that the reduced levels of glycolysis, TCA and fatty acid intermediates were associated 
with a corresponding decrease in the expression of key genes in all three metabolic pathways 
including GLUT2, GK, PC, PDH, MEc, CIC DIC, CPT1a and FAS (Figure 4). The novel finding 
that reducing ARNT/HIF-1┚ levels leads to a profound reduction in PC, DIC, and OGC 
expression levels and a reduction in glycoslysis and TCA metabolites, even though glucose 
oxidation and ATP production were unaltered, is an unexpected result. These collective 
changes in metabolite levels suggest that the oxidative entry of pyruvate into the TCA cycle is 
preserved in the absence of ARNT/HIF-1┚ at the expense of a loss of anaplerosis. A key role 
for anaplerosis in insulin secretion is supported by the finding that pyruvate flows into 
mitochondrial metabolic pathways, in roughly equal proportions, through the anaplerotic (PC) 
and oxidative (PDH) entry points. Glucose carbon entering through the PC reaction leads to an 
increase in TCA intermediates (called anaplerosis) (Schuit et al., 1997; Khan et al., 1996). In 
addition, beta-cells contain enzymes that allow “cycling” of pyruvate via its PC-catalyzed 
conversion to oxaloacetate (OAA), metabolism of OAA to malate, citrate, or isocitrate in the 
TCA cycle, and subsequent recycling of these metabolites to pyruvate via several possible  
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Fig. 3. Summary of the effects of siRNA mediated suppression of ARNT/HIF-1┚ in beta-
cells. Several key metabolites in both glycolysis and TCA cycle were negatively affected by 
the knockdown of ARNT/HIF-1┚. TCA, tricarboxylic acid cycle; DHAP, dihydroxyacetone 
phosphate; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase. 
 
Fig. 4. Effects of siRNA mediated suppression of ARNT/HIF-1┚ on key genes involved in 
the metabolic regulation of ┚-cell function in 832/13 cells. Gene expression is expressed as a 
percentage of the target gene from siControl treated cells and corrected for by an internal 
control gene cyclophilin E (Cyp). There was no significant difference seen between 
treatment groups for Cyp (n=5). HNF4a, hepatocyte nuclear factor-4┙; HNF1a, hepatocyte 
nuclear factor-1┙; HIF1a, hypoxia inducible factor 1┙; GK, glucokinase; GLUT2, glucose 
transporter-2; PLGg1, phospholipase ┛-1; PC, pyruvate carboxylase; PDHa1, pyruvate 
dehydrogenase (┙1 subunit); MEc, cytosolic malic enzyme; ICDc, cytosolic isocitrate 
dehydrogenase; CIC, citrate carrier; DIC, dicarboxylate carrier; OGC, ┙-ketoglutarate carrier; 
FAS, fatty acid synthase; CPT1a, Carnitine palmitoyl transferase 1┙. * P<0.05, ** P<0.01, *** 
P<0.001 siControl vs siARNT1. 
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combinations of cytosolic and mitochondrial pathways (MacDonald et al., 1995). Numerous 
groups have shown that both pyruvate cycling and anaplerosis are important to maintain 
normal secretory capacity of beta-cells (Lu et al., 2002; Joseph et al., 2006; MacDonald et al., 
2005; Ronnebaum et al., 2006). Since the amount of pyruvate is substantially lower in 
ARNT/HIF-1┚ depleted beta-cells, our data also suggests that this gene may play an 
important role in maintaining pyruvate cycling. However a direct link between ARNT/HIF-1┚ 
and pyruvate cycling has not yet been established. Figure 5 shows the diagrammatic 
representation of the transcriptional network regulated by ARNT/HIF-1┚ and its involvement 
glucose-stimulated anaplerosis and insulin release. 
 
Fig. 5. Schematic of the transcriptional network regulated by ARNT/HIF-1┚ and its 
involvement in glucose-stimulated anaplerosis and insulin release from beta-cells. 
ARNT/HIF-1┚ regulates key genes in glycolysis and TCA cycle (shown in blue), including 
key metabolite carriers such as DIC and OGC. MODY genes regulated by ARNT/HIF-1┚ are 
shown in green. Interestingly, ARNT/HIF-1┚ does not seem to play a significant role in the 
regulation ATP production in beta-cells, however, it seems to be very important for glucose-
induced anaplerosis, which provides crucial signals for GSIS. 
3.4 ARNT/HIF-1β regulates beta-cell and hepatic transcriptional networks  
Studies in ARNT/HIF-1┚ deficient beta-cells suggest that it plays a crucial role in the 
regulation of key genes involved in glucose metabolism and insulin secretion (Gunton et al., 
2005, Pillai et al., 2011). ARNT/HIF-1┚ target genes in beta-cells include the MODY1 and 
MODY3 genes HNF4┙ and HNF1┙, glucose metabolism genes GK, G6PI, PFK, aldolase, PC, 
PDH, MEc, DIC, OGC and insulin signaling genes IR, IRS2 and AKT2. In non-beta-cells it 
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has been shown that ARNT/HIF-1┚ is essential for the normal function of HIF-1┙, HIF2┙, 
and AhR. These heterodimeric complexes are required for cellular responses to hypoxia 
(HIF proteins) and environmental toxins (AhR), respectively (Kozak et al., 1997; Kewley et 
al., 2004). It has been estimated that there are more than 13,000 putative ARNT/HIF-1┚ 
binding sites in promoters in the human genome (Gunton et al., 2005). Many of the target 
gene promoters have multiple potential binding sites. Thus it is reasonable to estimate that a 
substantial decrease in ARNT/HIF-1┚ would affect the expression of a large number of 
genes in humans. Although there is a lack of direct biochemical evidence, many of the genes 
found to be altered in association with decreased ARNT/HIF-1┚ gene expression have 
putative ARNT/HIF-1┚-dimer consensus binding sites in their promoters (including 
HNF4┙, HNF1┙, Akt2, G6PI, PFK, and aldolase), suggesting a direct role for ARNT/HIF-1┚ 
containing dimers in the regulation of their expression (Figure 6). 
 
Fig. 6. Transcriptional network in pancreatic beta-cells regulated by ARNT/HIF-1┚. 
ARNT/HIF-1┚ regulates several key genes involved in glucose metabolism, insulin 
signaling and MODY. Beta-cell specific knockout of ARNT/HIF-1┚ in mice leads to reduced 
expression of a number of important beta-cell genes including HNF-4┙, HNF-1┙, insulin 
receptor (IR), insulin receptor substrate-2 (IRS2), protein kinase b (Akt2), glucokinase (GK), 
glucose-6-phosphoisomerase (G6PI), phosphofructokinase (PFK), aldolase (ALDO), 
pyruvate carboxylase (PC) and pyruvate dehydrogenase (PDH). 
In liver cells ARNT/HIF-1┚ has been shown to regulate the expression of several genes 
involved in glucose and lipid homeostasis. Support for the involvement of ARNT/HIF-1┚ 
in liver glucose homeostasis was provided by experiments showing that basal and 
insulin-induced expression of GLUT1, GLUT3, ALDO, PGK and VEGF were significantly 
reduced in ARNT/HIF-1┚-defective HepG2 cells (Salceda et al., 1996). Wang et al (2009) 
demonstrated that a reduction of ARNT/HIF-1┚ in liver cells was associated with an 
increase in the expression of several important gluconeogenic and lipogenic genes 
including PEPCK, G6Pase, SCD1, FXR, C/EBP┙, SREBP-1C, FBP-1 and FAS. The 
discovery that ARNT/HIF-1┚ may contribute to the regulation of beta-cell and hepatic 
genes suggests an essential role for this transcription factor in the regulation of glucose 
and lipid homeostasis (Figure 7). 
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Fig. 7. ARNT/HIF-1┚ regulates the expression of several key genes involved in 
gluconeogenesis, lipogenesis and ketogenesis in the liver cells. Liver-specific knockout of 
ARNT/HIF-1┚ in mice leads to increased hepatic gluconeogensis and lipogenesis with a 
corresponding increase in the expression of phosphoenolpyruvate carboxykinase (PEPCK), 
Glucose-6-phosphatase (G6Pase), Fructose-1,6-biphosphatase (FBP1), Steroyl–CoA-
desaturase (SCD1), Fatty acid synthase (FAS), CCAAT enhancer binding protein ┙ 
(C/EBP┙), sterol regulatory element binding protein (SREBP-1C) and Farsenoid X receptor 
(FXR). Adapted from Wang et al. (2009). 
3.5 Regulation of ARNT/HIF-1β in beta-cells 
Since ARNT/HIF-1┚ appears to be a major player in the pathogenesis of T2D, several 
attempts have been made to identify the upstream regulators of the gene in beta-cells. In 
2008, Dror et al., showed that glucose and endoplasmic reticulum Ca 2+ channels regulate the 
expression of ARNT/HIF-1┚ in beta-cells via presinilin. Presinilin is a protein that has been 
implicated in the cellular response to reduced metabolic activity (Koo and Koppen, 2004). 
Overexpression of presenilin-1 in clonal Min6 beta-cells increased ARNT/HIF-1┚ suggesting 
that ARNT/HIF-1┚ may be a downstream target of presenilin (Dror et al., 2008). They 
demonstrated that this pathway is controlled by Ca2+ flux through intracellular channels. 
ARNT/HIF-1┚ has also recently been shown to be regulated by the carbohydrate-responsive 
element-binding protein (ChREBP), which is a transcription factor shown to regulate 
carbohydrate metabolism in the liver and pancreatic beta-cells in response to elevated 
glucose concentrations (Noordeen et al., 2009). In a genome-wide approach using high-
density oligonucleotide arrays, the study showed that ChREBP binds directly to 
ARNT/HIF-1┚ promoter in Min6 clonal beta-cells. Accordingly, knockdown of ChREBP 
using siRNA resulted in an increase ARNT/HIF-1┚ mRNA levels whereas overexpression 
of ChREBP resulted in a decrease in ARNT/HIF-1┚ mRNA levels in rat. They also showed 
that incubating INS-1 (832/13) cells with glucose led to a substantial decrease in 
ARNT/HIF-1┚ mRNA levels. 
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Interestingly, it has also been shown that HIF-1┙, the highly regulated binding partner for 
ARNT/HIF-1┚, may be active under normoxic conditions in mouse and human beta-cells 
(Cheng et al., 2010). Coimmunoprecipitation studies demonstrated that HIF-1┙ was bound 
to ARNT/HIF-1┚ at the promoter region providing evidence for an interaction between 
HIF-1┙ and ARNT/HIF-1┚ in beta-cells. Treatment of diabetic mice with deferasirox (DFS), 
an agent that increases HIF-1┙ protein levels, improved glucose tolerance, normalized the 
expression of ARNT/HIF-1┚ and its target genes in human T2D islets. The same study also 
showed that HIF-2┙, but not AhR, is another possible binding partner for ARNT/HIF-1┚ in 
pancreatic beta-cells. These studies provide a novel mechanism to regulate ARNT/HIF-1┚ 
gene expression in beta-cells.  
Three studies published from independent laboratories studying the impact of increasing 
HIF-1┙ levels in beta-cells indicate that one has to be extremely cautious when using 
pharmacological agents, such as DFS, to activate HIF-1┙ in the islets (Puri et al., 2008; 
Zehetner et al., 2008; Cantley et al., 2009). These studies used the Cre-loxP system to 
conditionally delete VHL gene in beta-cells and showed that there were adverse effects 
associated with an increase in HIF-1┙ levels on beta-cell function. In all the three studies, 
increased HIF-1┙ levels were accompanied by severely impaired GSIS and increased lactate 
production, indicating a switch from aerobic to anaerobic glycolysis. Thus there appears to 
be a dose-response curve for the affects HIF-1┙ protein levels on beta-cell function (Cheng et 
al., 2010). Although complete lack of HIF-1┙ seems deleterious to GSIS in mice and Min6 
cells, milder increases are beneficial for beta-cell function. As seen in VHL knockout mice, 
very high levels of HIF-1┙ are detrimental for normal beta-cell function. Therefore, before 
we begin to develop a novel treatment regime that enhances HIF-1┙ or ARNT/HIF-1┚ 
activity in human diabetic islets, it is imperative that we understand the expected outcomes 
of such changes to avoid any detrimental effects.  
4. Concluding remarks 
It is well known that ARNT/HIF-1┚ plays a role in the cellular responses to hypoxia, 
however recent research has demonstrated a broader role for this transcription factor in 
maintaining glucose and lipid homeostasis in type 2 diabetics. It is now clear that a 
significant decrease in ARNT/HIF-1┚ gene expression in both the pancreatic beta-cells and 
the liver cells is deleterious and can result in T2D. Conversely, targeted disruption of 
ARNT/HIF-1┚ gene expression in the adipocytes followed by treatment of mice with a high 
fat diet improves insulin sensitivity and decreases adiposity (Jiang et al., 2011). A central role 
for ARNT/HIF-1┚ in the regulation of key genes involved in glucose sensing, GSIS and 
insulin signaling in rodents as well in human islets suggest it plays an important role in 
maintaining normal beta-cell function. Current studies support the idea that ARNT/HIF-1┚ 
could act as an upstream regulator of many of the key genes involved in glucose and lipid 
homeostasis. Clearly, the transcriptional network regulated by ARNT/HIF-1┚ and genes 
that are under direct or indirect control of this transcription factor is very broad and hence 
any change in the regulation of ARNT/HIF-1┚ may have an impact on many signaling 
pathways. The fact that ARNT/HIF-1┚ is a binding partner for several other 
Per/ARNT/Sim transcription factor family members like HIF-1┙, HIF-2┙, HIF-3┙ and AhR 
makes it a significant member of this family of transcription factors. Improving our 
understanding of the beta-cell transcription factors, establishing their mechanism of action 
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and hierarchy and finding ways to regulate their expression could prove beneficial in 
developing novel tools to prevent or correct beta-cell dysfunction in T2D.  
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